US FDA conducts GMP inspection at Piramal Pharma's Digwal facility

US FDA conducts GMP inspection at Piramal Pharma's Digwal facility

The inspection that was held from March 27 to March 31 was completed successfully with Zero Form -483 observations.

FPJ Web DeskUpdated: Saturday, April 01, 2023, 04:11 PM IST
article-image
US FDA conducts GMP inspection at Piramal Pharma's Digwal facility | Image: Piramal Pharma (Representative)

The US FDA's Good Manufacturing Practices Inspection of Piramal Pharma Limited's Digwal facility was completed successfully, the company said through an exchange filing. The inspection that was held from March 27 to March 31 was completed successfully with Zero Form -483 observations.

The company in an exchange filing said, "The company is committed to maintaining the highest standards of compliance."

Piramal Pharma shares

The shares of Piramal Pharma on Friday closed at Rs 68.75, up by 2.54 per cent.

RECENT STORIES

Shriram Finance Plans To Raise $1 Billion From Overseas In Next 6 Months

Shriram Finance Plans To Raise $1 Billion From Overseas In Next 6 Months

Be A Fan Of Comfort: New Petrol Volvo XC90 Revealed

Be A Fan Of Comfort: New Petrol Volvo XC90 Revealed

Adani Floats China Subsidiary For Providing Project Management Services

Adani Floats China Subsidiary For Providing Project Management Services

Nikkei, KOSPI And Other Major Asian Indices Close Blood Red Week With Mammoth Decline

Nikkei, KOSPI And Other Major Asian Indices Close Blood Red Week With Mammoth Decline

'Tesla Faster Than Mclaren': Elon Musk On His Model S Car

'Tesla Faster Than Mclaren': Elon Musk On His Model S Car